Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2026

Conditions

Basilar Artery OcclusionPosterior Circulation Brain Infarction

Interventions

DRUG

Cerebrolysin

The Cerebrolysin will be administered at least one hour after the standard treatment and no later than 24 hours after the stroke symptom onset.